Parag Mallick - 08 May 2025 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Chief Scientist, Director, 10%+ Owner
Signature
/a/ Anna Mowry, as Attorny-in-Fact
Issuer symbol
NAUT
Transactions as of
08 May 2025
Net transactions value
+$9,885
Form type
4
Filing time
12 May 2025, 19:19:33 UTC
Previous filing
04 Mar 2025
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mallick Parag Chief Scientist, Director, 10%+ Owner C/O NAUTILUS BIOTECHNOLOGY, INC., 2701 EASTLAKE AVENUE EAST, SEATTLE /a/ Anna Mowry, as Attorny-in-Fact 12 May 2025 0001857948

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $8,788 +12,000 +0.06% $0.7323 20,491,892 08 May 2025 Direct F1
transaction NAUT Common Stock Purchase $1,098 +1,500 +0.01% $0.7317 20,493,392 12 May 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.